Poliscio Analytics LLC
  • Daily Alerts
  • Insights
    • Our Insights Articles
    • Project 2025
  • FOIAengine
    • Log In
    • About FOIA Engine
    • Trial User Signup
    • User Support
    • How to Use
  • FOIA Services
  • About
    • About PoliScio
    • Leadership
    • Newsroom
  • Contact
Select Page
Perp Walk: “Wild West” Gold Rush in a $90 Trillion Market

Perp Walk: “Wild West” Gold Rush in a $90 Trillion Market

by John A. Jenkins | Jun 4, 2026 | CFTC, Cryptocurrency, FOIA, News Media, Politics

FOIAengine: Requests Pile Up, As State and Federal Lawmakers Square Off Months before the regulatory chaos around prediction markets exploded into courtrooms, state houses, and the White House, sophisticated observers were already paying attention. More than 170...
Hard Questions for NASA Amid Warning of Russian Cyberattacks

Hard Questions for NASA Amid Warning of Russian Cyberattacks

by John A. Jenkins | May 20, 2026 | FOIA, NASA

FOIA Requests From Former CIA, FBI agents  Across the United States, cybersecurity teams at federal agencies, defense contractors, telecom firms, and critical infrastructure operators are being warned to prepare for the next Russian cyberattack. In March, the Federal...
A Litigation Wave for Biotech’s Medpace

A Litigation Wave for Biotech’s Medpace

by John A. Jenkins | May 14, 2026 | FOIA, Litigation, Pharmaceuticals, SEC

FOIAengine: Requests to SEC Preceded Stock Troubles and a Surprise Resignation For a company that most Americans have never heard of, Medpace Holdings, Inc. (NASD:MEDP) sits remarkably close to the center of the modern drug-development economy. The Cincinnati-based...
How Requesters Use FOIA to Asses Biopharma Risks

How Requesters Use FOIA to Asses Biopharma Risks

by Randy Miller | May 6, 2026 | FDA, FOIA, Hedge Funds, Pharmaceuticals, Short-Selling, Stock Market

FOIAengine: Assessments Include Operational, Clinical and Commercial Threats Freedom of Information Act requests to the Food and Drug Administration during March illustrated three of the primary uncertainties facing U.S. drug manufacturers and their investors: the...
Hard Questions for NASA Amid Warning of Russian Cyberattacks

News Media FOIA Requests Target EPA’s Zeldin

by Randy Miller | Apr 22, 2026 | EPA, FOIA, News Media, Politics

FOIAengine: Journalists Seek EPA Communications on Iran Bombing A small circle of reporters – concentrated overwhelming at one news organization – is using the Freedom of Information Act to run what amounts to a systematic, real-time audit of Environmental Protection...
How Requesters Use FOIA to Asses Biopharma Risks

Beta Bionics: The Rise and Decline of a High-Flying IPO

by John A. Jenkins | Apr 9, 2026 | FDA, FOIA, Litigation, Medical Devices, Short-Selling, Stock Market

How FOIA Requests Signaled Problems With a “Bionic Pancreas”  At a federal advisory panel meeting in 2018, a biomedical engineer named Ed Damiano stepped to the microphone – not just as a scientist. “I’m also a father,” he told regulators, describing his son’s...
« Older Entries
  • Terms of Service
  • Privacy Policy
  • Text-to-Speech
Copyright 2026 PoliScio Analytics LLC